Decoding the role of CD4 T cells in driving autoimmune type 1 diabetes 2333351
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.1831 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Ian McBain und 5 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease where CD8 T cells eliminate insulin-producing β cells in the pancreatic islets. Yet, MHC class II haplotypes confer the greatest genetic risk for the development of T1D, suggesting a critical role for CD4 T cells. Employing the non-obese diabetic (NOD) mouse model, our lab identified in the pancreatic lymph node (pLN) a stem-like β cell-specific CD8 T cell pool required to initiate and sustain disease: pLN β cell-specific stem-CD8 T cells self-renew and continuously give rise to differentiated progenies which migrate to the pancreas (PA) and eliminate β cells; the pLN stem-CD8 T cell pool is absolutely required to sustain β cell destruction. Given the importance of autoimmune stem-CD8 T cells and the association of MHC class II in T1D pathogenesis, we wanted to understand the role of CD4 T cells in autoimmune CD8 T cell stemness and differentiation.
Methods
We employed the NOD model and longitudinally assessed the phenotypic and functional characteristics of β cell-specific CD4 T cells using flow cytometry, serial transplantation, CRISPR/Cas9-mediated gene editing, and transcriptomic studies.
Results
Our studies reveal, for the first time, how CD4 T cells drive autoimmune CD8 T cell stemness, differentiation, and pathogenicity. We find β cell-specific CD4 T cells in pLN and PA reveal two distinct populations based on their expression of TCF1, a transcription factor critical for stemness and self-renewal. Functional studies identify pLN TCF1hi CD4 T cells as stem-T cell subset needed to drive the generation and maintenance of autoimmune stem-CD8 T cells in pLN, their differentiation into β cell-destroying cytotoxic effector cells, and ultimately T1D.
Conclusion
A unique population of β cell-specific CD4 T cells in pLN is critical for autoimmune CD8 T cell stemness, differentiation and disease. Identifying therapeutic strategies that target autoimmune stem-CD4 T cells could emerge as powerful approaches for the treatment of T1D. Funding Source NIH grant 1F31DK145180, NIH grant R01AI173249, Juvenile Diabetes Research Foundation grant JDRF SRA-2023-1410-S-B, Topic Categories Basic Autoimmunity (BA)
Zitieren
APA
McBain, I., Zumbo, P., Miakicheva, S., Hawley, K., Betel, D., & Schietinger, A. (2026). Decoding the role of CD4 T cells in driving autoimmune type 1 diabetes 2333351. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1831
Vancouver
McBain I, Zumbo P, Miakicheva S, Hawley K, Betel D, Schietinger A. Decoding the role of CD4 T cells in driving autoimmune type 1 diabetes 2333351. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1831
BibTeX
@article{McBain2026,
author = {McBain, Ian and Zumbo, Paul and Miakicheva, Svetlana and Hawley, Katrina and Betel, Doron and Schietinger, Andrea},
title = {Decoding the role of CD4 T cells in driving autoimmune type 1 diabetes 2333351},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.1831}
}
EUVIMED